SCHEMBL14101437

SCHEMBL14101437

c1ccc(-c2cc(-c3ccccc3)c3ccc4c(-c5ccc6sc7ccc(-c8ccc9ccc%10c(-c%11ccccc%11)cc(-c%11ccccc%11)c%11ccc8c9c%10%11)cc7c6c5)ccc5ccc2c3c54)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 3/20 0.38
PIM3 Q86V86 1/20 0.35
CHEK1 O14757 1/20 0.34
WEE1 P30291 1/20 0.34
SLC9A1 P19634 2/20 0.34
LIMK1 P53667 1/20 0.33
S1PR4 O95977 4/20 0.32
S1PR5 Q9H228 4/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
MPI P34949 1/20 0.32
KMT2A Q03164 1/20 0.32
ALOX5 P09917 1/20 0.32
ROCK1 Q13464 1/20 0.32
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
ERBB2 P04626 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101429 0.95 F9 (0.40) F9PIM3CHEK1WEE1SLC9A1
SCHEMBL14101668 0.94 F9 (0.39) F9PIM3CHEK1WEE1SLC9A1
SCHEMBL14101430 0.94 F9 (0.39) F9PIM3CHEK1WEE1SLC9A1
SCHEMBL14101457 0.93 PIM3 (0.41) F9PIM3CHEK1WEE1SLC9A1
SCHEMBL14101667 0.93 PIM3 (0.41) F9PIM3CHEK1WEE1SLC9A1
SCHEMBL14101670 0.91 F9 (0.40) F9PIM3CHEK1WEE1SLC9A1
SCHEMBL14101524 0.91 GPR3 (0.41) F9PIM3CHEK1WEE1SLC9A1
SCHEMBL14101475 0.91 F9 (0.40) F9PIM3CHEK1WEE1SLC9A1
SCHEMBL14101427 0.91 F9 (0.40) F9PIM3CHEK1WEE1SLC9A1
SCHEMBL14101487 0.91 GPR3 (0.41) F9PIM3CHEK1WEE1SLC9A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR F9 3290/4885PIM3 2288/4885CHEK1 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.